Essentia Health Grand Rapids Clinic Clinic/Center - Multi-Specialty Medicare: Not Enrolled in Medicare Practice Location: 1542 Golf Course Rd Ste 202, Grand Rapids, MN 55744 Phone: 218-999-7000 |
Essentia Health Grand Rapids Clinic Clinic/Center - Multi-Specialty Medicare: Not Enrolled in Medicare Practice Location: 1542 Golf Course Rd Ste 204, Grand Rapids, MN 55744 Phone: 218-999-7000 |
Birchtree Health Pllc Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 516 S Pokegama Ave, Grand Rapids, MN 55744 Phone: 218-256-4456 |
New Spirit Women's Clinic Pa Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 409 Se 13th St, Grand Rapids, MN 55744 Phone: 218-326-9100 Fax: 218-326-9200 |
Grand Itasca Clinic And Hospital Clinic/Center Medicare: Medicare Enrolled Practice Location: 1601 Golf Course Rd, Grand Rapids, MN 55744 Phone: 218-326-3401 Fax: 218-999-1461 |
North Central Cardiovascular Diagnostics, Llc Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 111 Se 3rd St, Grand Rapids, MN 55744 Phone: 218-326-3401 |
News Archive
A new study published on the online preprint server medRxiv in May 2020 reports on the high incidence of delirium in COVID-19 patients in intensive care. This highlights the urgent need to predict, prevent, and manage delirium and to cut it short in patients with COVID-19.
Stem cells that glow like fireflies could someday help doctors heal damaged hearts without cutting into patients' chests.In his University of Central Florida lab, Steven Ebert engineered stem cells with the same enzyme that makes fireflies glow. The "firefly" stem cells glow brighter and brighter as they develop into healthy heart muscle, allowing doctors to track whether and where the stem cells are working.
A major 12-year study based on a Taiwanese population cohort has demonstrated that not only does diabetes increase the risk of developing Parkinson's disease more than 2-fold, the use of sulfonylureas, commonly used as treatment for diabetes, increases the risk further by about 57%. This study also found that by including metformin in the therapy, no increased risk in developing Parkinson's disease was recorded.
StemCells, Inc. announced today that is has received authorization from Swissmedic, the Swiss regulatory agency for therapeutic products, to initiate a Phase I/II clinical trial in Switzerland of the Company's proprietary HuCNS-SCĀ® product candidate (purified human neural stem cells) in chronic spinal cord injury. The trial is designed to assess both safety and preliminary efficacy in patients with varying degrees of paralysis who are three to 12 months post-injury, and will progressively enroll patients based upon the severity of injury.
Introducing the Reposa Synergy by Alpine HC, an innovative hybrid mattress system that exemplifies synergy by combining exceptional comfort through specialist foams, with effective pressure distribution using integral air-foam cells. The end result? A superior pressure relieving experience for the user.
› Verified 2 days ago